US Stock MarketDetailed Quotes

VRDN Viridian Therapeutics

Watchlist
  • 15.490
  • +0.570+3.82%
Close Aug 16 16:00 ET
  • 15.490
  • 0.0000.00%
Post 18:13 ET
989.65MMarket Cap-3644P/E (TTM)

Viridian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0.00%72K
-26.53%72K
-82.28%314K
-31.43%72K
-93.97%72K
-71.88%72K
-54.63%98K
-40.20%1.77M
-50.93%105K
474.52%1.2M
Operating revenue
0.00%72K
-26.53%72K
-82.28%314K
-31.43%72K
-93.97%72K
-71.88%72K
-54.63%98K
-40.20%1.77M
-50.93%105K
474.52%1.2M
Cost of revenue
Gross profit
Operating expense
21.76%72.26M
-22.88%55.97M
87.22%254.76M
45.51%71.55M
65.58%51.3M
99.02%59.35M
178.00%72.57M
64.56%136.08M
67.85%49.17M
116.01%30.98M
Selling and administrative expenses
-16.60%16.07M
-31.18%15.03M
170.02%95M
234.82%32.99M
135.99%20.91M
137.59%19.26M
161.17%21.83M
36.34%35.18M
42.79%9.85M
42.44%8.86M
-General and administrative expense
-16.60%16.07M
-31.18%15.03M
170.02%95M
234.82%32.99M
135.99%20.91M
137.59%19.26M
161.17%21.83M
36.34%35.18M
42.79%9.85M
42.44%8.86M
Research and development costs
40.19%56.19M
-19.31%40.94M
58.35%159.77M
-1.93%38.56M
37.37%30.39M
84.61%40.08M
185.92%50.74M
77.36%100.89M
75.57%39.32M
172.37%22.12M
Operating profit
-21.78%-72.19M
22.87%-55.9M
-89.46%-254.45M
-45.68%-71.48M
-71.98%-51.22M
-100.50%-59.28M
-179.94%-72.47M
-68.45%-134.3M
-68.72%-49.07M
-110.73%-29.79M
Net non-operating interest income expense
70.80%7.19M
70.18%7.36M
277.34%16.72M
40.75%4.62M
305.00%3.56M
5,669.86%4.21M
2,105.10%4.32M
1,306.35%4.43M
2,330.37%3.28M
867.03%880K
Non-operating interest income
77.96%7.79M
77.00%7.94M
277.60%18.56M
60.45%5.53M
298.85%4.16M
1,828.63%4.38M
2,189.29%4.49M
1,445.91%4.92M
2,399.28%3.45M
1,047.25%1.04M
Non-operating interest expense
259.64%597K
255.76%587K
280.04%1.85M
445.24%916K
265.85%600K
7.79%166K
--165K
16,100.00%486K
5,500.00%168K
--164K
Other net income (expense)
Income before tax
-18.03%-64.99M
28.77%-48.54M
-83.05%-237.73M
-46.03%-66.86M
-64.88%-47.66M
-86.71%-55.06M
-165.25%-68.15M
-63.54%-129.87M
-58.17%-45.79M
-105.83%-28.91M
Income tax
Net income
-18.03%-64.99M
28.77%-48.54M
-83.05%-237.73M
-46.03%-66.86M
-64.88%-47.66M
-86.71%-55.06M
-165.25%-68.15M
-63.54%-129.87M
-58.17%-45.79M
-105.83%-28.91M
Net income continuous Operations
-18.03%-64.99M
28.77%-48.54M
-83.05%-237.73M
-46.03%-66.86M
-64.88%-47.66M
-86.71%-55.06M
-165.25%-68.15M
-63.54%-129.87M
-58.17%-45.79M
-105.83%-28.91M
Minority interest income
Net income attributable to the parent company
-18.03%-64.99M
28.77%-48.54M
-83.05%-237.73M
-46.03%-66.86M
-64.88%-47.66M
-86.71%-55.06M
-165.25%-68.15M
-63.54%-129.87M
-58.17%-45.79M
-105.83%-28.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-18.03%-64.99M
28.77%-48.54M
-83.05%-237.73M
-46.03%-66.86M
-64.88%-47.66M
-86.71%-55.06M
-165.25%-68.15M
-63.54%-129.87M
-58.17%-45.79M
-105.83%-28.91M
Basic earnings per share
19.69%-1.02
50.93%-0.79
-31.11%-5.31
-19.47%-1.35
-26.74%-1.09
-19.81%-1.27
-64.29%-1.61
39.19%-4.05
6.61%-1.13
31.20%-0.86
Diluted earnings per share
19.69%-1.02
50.93%-0.79
-31.11%-5.31
-19.47%-1.35
-26.74%-1.09
-19.81%-1.27
-64.29%-1.61
39.19%-4.05
6.61%-1.13
31.20%-0.86
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0.00%72K-26.53%72K-82.28%314K-31.43%72K-93.97%72K-71.88%72K-54.63%98K-40.20%1.77M-50.93%105K474.52%1.2M
Operating revenue 0.00%72K-26.53%72K-82.28%314K-31.43%72K-93.97%72K-71.88%72K-54.63%98K-40.20%1.77M-50.93%105K474.52%1.2M
Cost of revenue
Gross profit
Operating expense 21.76%72.26M-22.88%55.97M87.22%254.76M45.51%71.55M65.58%51.3M99.02%59.35M178.00%72.57M64.56%136.08M67.85%49.17M116.01%30.98M
Selling and administrative expenses -16.60%16.07M-31.18%15.03M170.02%95M234.82%32.99M135.99%20.91M137.59%19.26M161.17%21.83M36.34%35.18M42.79%9.85M42.44%8.86M
-General and administrative expense -16.60%16.07M-31.18%15.03M170.02%95M234.82%32.99M135.99%20.91M137.59%19.26M161.17%21.83M36.34%35.18M42.79%9.85M42.44%8.86M
Research and development costs 40.19%56.19M-19.31%40.94M58.35%159.77M-1.93%38.56M37.37%30.39M84.61%40.08M185.92%50.74M77.36%100.89M75.57%39.32M172.37%22.12M
Operating profit -21.78%-72.19M22.87%-55.9M-89.46%-254.45M-45.68%-71.48M-71.98%-51.22M-100.50%-59.28M-179.94%-72.47M-68.45%-134.3M-68.72%-49.07M-110.73%-29.79M
Net non-operating interest income expense 70.80%7.19M70.18%7.36M277.34%16.72M40.75%4.62M305.00%3.56M5,669.86%4.21M2,105.10%4.32M1,306.35%4.43M2,330.37%3.28M867.03%880K
Non-operating interest income 77.96%7.79M77.00%7.94M277.60%18.56M60.45%5.53M298.85%4.16M1,828.63%4.38M2,189.29%4.49M1,445.91%4.92M2,399.28%3.45M1,047.25%1.04M
Non-operating interest expense 259.64%597K255.76%587K280.04%1.85M445.24%916K265.85%600K7.79%166K--165K16,100.00%486K5,500.00%168K--164K
Other net income (expense)
Income before tax -18.03%-64.99M28.77%-48.54M-83.05%-237.73M-46.03%-66.86M-64.88%-47.66M-86.71%-55.06M-165.25%-68.15M-63.54%-129.87M-58.17%-45.79M-105.83%-28.91M
Income tax
Net income -18.03%-64.99M28.77%-48.54M-83.05%-237.73M-46.03%-66.86M-64.88%-47.66M-86.71%-55.06M-165.25%-68.15M-63.54%-129.87M-58.17%-45.79M-105.83%-28.91M
Net income continuous Operations -18.03%-64.99M28.77%-48.54M-83.05%-237.73M-46.03%-66.86M-64.88%-47.66M-86.71%-55.06M-165.25%-68.15M-63.54%-129.87M-58.17%-45.79M-105.83%-28.91M
Minority interest income
Net income attributable to the parent company -18.03%-64.99M28.77%-48.54M-83.05%-237.73M-46.03%-66.86M-64.88%-47.66M-86.71%-55.06M-165.25%-68.15M-63.54%-129.87M-58.17%-45.79M-105.83%-28.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -18.03%-64.99M28.77%-48.54M-83.05%-237.73M-46.03%-66.86M-64.88%-47.66M-86.71%-55.06M-165.25%-68.15M-63.54%-129.87M-58.17%-45.79M-105.83%-28.91M
Basic earnings per share 19.69%-1.0250.93%-0.79-31.11%-5.31-19.47%-1.35-26.74%-1.09-19.81%-1.27-64.29%-1.6139.19%-4.056.61%-1.1331.20%-0.86
Diluted earnings per share 19.69%-1.0250.93%-0.79-31.11%-5.31-19.47%-1.35-26.74%-1.09-19.81%-1.27-64.29%-1.6139.19%-4.056.61%-1.1331.20%-0.86
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg